Adenocarcinoma of the Esophagogastric Junction (eBook, PDF)

• Format: PDF

Produktbeschreibung

Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. This special volume, with contributions from experts in the field, covers all aspects of the disease. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are addressed. Detailed attention is also paid to other important recent developments, including molecular response prediction, early metabolic response evaluation by PET and PET-CT, the diagnosis of micrometastases, and the use of sentinel node technology. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy.

Produktdetails

• Verlag: Springer Berlin
• Erscheinungstermin: 2. August 2010
• Englisch
• ISBN-13: 9783540705796
• Artikelnr.: 37368124

Inhaltsangabe

Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction.- Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction.- The Pathogenesis of Barrett’s Metaplasia and the Progression to Esophageal Adenocarcinoma.- Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Staging of Adenocarcinoma of the Esophagogastric Junction.- Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction.- Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach.- Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction.- Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction.- Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.- Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

---

Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction.- Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction.- The Pathogenesis of Barrett's Metaplasia and the Progression to Esophageal Adenocarcinoma.- Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Clinical Staging of Adenocarcinoma of the Esophagogastric Junction.- Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction.- Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach.- Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction.- Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction.- Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third.- Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.- Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.

Rezensionen

From the reviews:

"Adenocarcinoma of the Esophagogastric Junction provides today's most comprehensive and tailored description of the pathogenesis, diagnosis, staging, and therapy of malignancy of a single region within the upper digestive tract. ... The chapters are succinct and well written, and the topics follow a logical progression of thought. ... one reads through, a sense of 'order' is appreciated and this ultimately frames the barriers that exist in the care of these patients. I left this text with many new perspectives and a sense of 'purpose.'" (Blair A. Jobe, Journal of Gastrointestinal Cancer, Vol. 43, 2012)